The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / RA Choice: A Tool to Improve Patient Literacy

RA Choice: A Tool to Improve Patient Literacy

July 5, 2016 • By Arthritis Care & Research

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Shared decision making requires patients and clinicians to share information about safety, efficacy and treatment burden. But over the past two decades, the expansion of medications for patients with rheumatoid arthritis (RA) has increased the complexity of doctor-patient communication and determining treatment. Additional communication issues, such as language barriers, limited time and lack of health literacy, limit shared decision making and may even affect patient outcome.

You Might Also Like
  • How Does Health Literacy Affect the Patient Global Assessment?
  • Online Tool Helps RA Patients Make Informed Decisions
  • Meaningful Use and Patient Engagement – Supporting eHealth Literacy

“We have found that nearly one-third of adults with RA report suboptimal shared decision-making communication with their clinicians,” write Jennifer L. Barton, MD, of the Oregon Health & Science University in Portland, and her colleagues in their latest research paper. Additionally, “RA patients who are nonwhite, immigrants or who have limited English-language proficiency have higher disease activity and poorer function despite access to effective therapies.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Barton and colleagues designed a low-literacy medication guide and decision aid, called RA Choice. Developed in three languages, the program facilitates treatment-related conversations between patients and clinicians to increase patient knowledge and potentially support shared decision making. The program’s efficacy and clinical feasibility were assessed during a practice-based pilot study, the results of which were published in the July 2016 issue of Arthritis Care & Research.

Participants had to have RA, have failed treatment with at least one disease-modifying anti-rheumatic drug and fulfill one of the following criteria: age >65, immigrant, non-English speaker, less than high school education, limited health literacy and racial/ethnic minority. One-hundred and sixty-six patients were sorted into three groups: 1) the control group with patients receiving existing medication guidelines at visits, 2) a group using only the adapted medication guide prior to visits, and 3) a group using both the adapted medication guide before visits plus the decision aid during visits.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The primary endpoints were increased patient knowledge and decreased decisional conflict. Data were collected during post-visit interviews at one week, three months and six months.

The Results
“The use of a multilingual, literacy appropriate medication guide and decision tool was acceptable and feasible to vulnerable populations with RA and their clinicians, and increased knowledge,” write the authors in their discussion.

Groups 2 and 3 demonstrated an adequate RA knowledge immediately post visit—63% and 78%, respectively, higher than the control group. Patients who had a medication change (n=65) and were in the intervention groups had a lower (better) mean decisional conflict score immediately post visit. The secondary outcomes of trust in physician and shared decision-making communication did not differ by group. The authors write, “The interventions did not impact secondary outcomes of trust, shared decision-making communication, adherence or change in function at six months.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: Conditions, Rheumatoid Arthritis Tagged With: Arthritis Care & Research, learning tools, Medication, patient communication, patient education

You Might Also Like:
  • How Does Health Literacy Affect the Patient Global Assessment?
  • Online Tool Helps RA Patients Make Informed Decisions
  • Meaningful Use and Patient Engagement – Supporting eHealth Literacy
  • When Rheumatologists Are a Patient’s Second or Third Choice for Medical Opinion

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.